T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Saturday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of NASDAQ TTOO opened at $0.18 on Friday. The business has a fifty day simple moving average of $0.28 and a 200 day simple moving average of $1.30. T2 Biosystems has a one year low of $0.06 and a one year high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.